CSL buys stem cell therapy firm Calimmune – The Australian
The Australian |
CSL buys stem cell therapy firm Calimmune
The Australian The purchase of US-based biotech Calimmune will expand the offering of CSL Behring, which is the plasma arm of CSL focused on treatments for haemophilia. Calimmune's lead development programs are ex vivo haematopoietic stem cell (HSC) gene … CSL acquires biotech company & stem cell gene platform Is CSL Limited buying its way to growth? In The News |
